Featured Meetings and Events A calendar of scientific meetings and events sponsored by the National Institutes of Health is available at http://calendar.nih.gov /cgi-bin/calendar

Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01 and R21)
PA-05-137
Application Receipt Dates: Oct. 1, 2005; Feb. 1, June 1, and Oct. 1, 2006; Feb. 1, June 1, and Oct. 1, 2007; Feb. 1 and June 1, 2008

This funding opportunity will use the R01 and R21 award mechanisms. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa
_id=2846.

Inquiries: Dr. John Cole - jc121b@nih.gov; Dr. Asad Umar - au17z@mail.nih.gov; Dr. Heng Xie - XieHe@mail.nih.gov

Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01)
PA-05-138
Application Receipt Dates: Oct. 1, 2005; Feb. 1, June 1, and Oct. 1, 2006; Feb. 1, June 1, and Oct. 1, 2007; Feb. 1 and June 1, 2008

This funding opportunity will use the P01 award mechanism.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2847.

Inquiries: Dr. John Cole - jc121b@nih.gov; Dr. Asad Umar - au17z@mail.nih.gov; Dr. Heng Xie - XieHe@mail.nih.gov

Short-Term Courses in Human Embryonic Stem Cell Culture Techniques
PAR-05-133
Letter of Intent Receipt Date: August 8, 2005.
Application Receipt Date: September 8, 2005

This is a renewal of PA-02-054. This funding opportunity will use the T15 award mechanism.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2848.

Inquiries: Dr. John Sogn - JS150x@nih.gov

Ruth L. Kirschstein NRSA Fellowships in Cancer Nanotechnology Research
RFA-CA-06-010
Application Receipt Date: November 16, 2005

This funding opportunity will use the F32 and F33 award mechanisms.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2849.

Inquiries: Dr. Gregory J. Downing - downingg@mail.nih.gov

Research on Research Integrity
RFA-NR-06-001
Letter of Intent Receipt Date: August 16, 2005.
Application Receipt Date: September 16, 2005

This is a renewal of RFA-NS-05-003. This funding opportunity will use the R01 award mechanism.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2850.

Inquiries: Dr. Ann O'Mara - Omaraa@mail.nih.gov.

For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchandfunding.

The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.